Skip to main content
Log in

Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2

  • Short Communications
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

HI-6 is presently considered the most potent oxime antidote against soman poisoning in mice, rats, dogs and monkeys. However, it is still an open question whether efficiency of HI-6, observed in experimental animals, can be extrapolated to soman intoxicated humans. In this paper efficiency of HI-6 and possible mechanisms of action were compared in rat and human fresh muscle preparations. In rat muscle, about 50% of control AChE activity could be recovered by both therapeutic (5 min after soman) and prophylactic (5 min before soman) application of HI-6. On the other hand, in human muscle therapeutic treatment restored only 5%, while prophylactic application of HI-6 again resulted in about 50% recovery of control AChE activity. As revealed by comparison of the prophylactic effects of HI-6 and the non-oxime bispyridinium compound SAD-128, competitive inhibition of AChE plays a minor role as a protective mechanism. Immediate reactivation of rapidly aging human AChE must therefore be instituted for successful protective treatment by HI-6. Retardation of aging, a direct effect of SAD-128, was roughly estimated to improve reactivation by HI-6 for about 10% of control AChE activity of the human muscle. PAM-2 proved completely inefficient as a therapeutic and as a prophylactic agent on both rat and human muscle preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Clement JG (1981) Toxicology and pharmacology of bispyridinium oximes — insight into the mechanism of action of soman poisoning in vivo. Fundam Appl Toxicol 1: 193–202

    Google Scholar 

  • De Jong LPA, Wolring GZ (1980) Reactivation of acetylcholinesterase inhibited by 1,2,2-trimethylpropylmethyl phosphonofluoridate (soman) with HI-6 and related oximes. Biochem Pharmacol 29: 2379–2387

    Google Scholar 

  • De Jong LPA, Wolring GZ (1984) Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterase from various species including man, inhibited by soman. Biochem Pharmacol 33: 1119–1125

    Google Scholar 

  • Grubič Z, Sketelj J, Klinar B, Brzin M (1981) Recovery of acetylcholinesterase in the diaphragm, brain and plasma of the rat after irreversible inhibition by soman: a study of cytochemical localization and molecular forms of the enzyme in the motor end plate. J Neurochem 37: 909–916

    Google Scholar 

  • Harris LW, Heyl WC, Stitcher DL, Broomfield CA (1978) Effects of 1,1′-oxydimethylene bis-(4- tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman and sarin-inhibited cholinesterase by oximes. Biochem Pharmacol 27: 757–761

    Google Scholar 

  • Lewis MK, Eldefrawi ME (1974) A simple, rapid and quantitative radiometric assay of acetylcholinesterase. Anal Biochem 57: 588–592

    Google Scholar 

  • Maksimović M, Bošković B, Radović L, Tadić V, Deljać V, Binenfeld Z (1980) Antidotal effects of bis-pyridinium-2-mono-oxime carbonyl derivatives in intoxications with highly toxic organophosphorous compounds. Acta Pharm Jugosl 30: 151–160

    Google Scholar 

  • Puu G, Artursson E, Bucht G (1986) Reactivation of nerve agent inhibited human acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 25: 1505–1510

    Google Scholar 

  • Schoene K, Steinhanses J, Oldiges H (1976) Protective activity of pyridinium salts against soman poisoning in vivo and in vitro. Biochem Pharmacol 25: 1955–1958

    Google Scholar 

  • Schoene K, Steinhanses J, Oldiges H (1983) Reactivation of soman inhibited acetylcholinesterase in vitro and protection against soman in vivo by bispyridinium-2 -aldoximes. Biochem Pharmacol 32: 1649–1651

    Google Scholar 

  • Smith AP, Van der Wiel HJ, Wolthuis OL (1981) Analysis of oxime-induced neuromuscular recovery in guinea pig, rat and man following soman poisoning in vitro. Eur J Pharmacol 70: 371–379

    Google Scholar 

  • Van Helden HPM, Wolthuis OL (1983) Evidence of intramuscular depot of the cholinesterase inhibitor soman in the rat. Eur J Pharmacol 89: 271–274

    Google Scholar 

  • Van Helden HPM, Van der Wiel HJ, Wolthuis OL (1983b) Therapy of organophosphate poisoning: the marmoset as a model for man. Br J Pharmacol 78: 579–589

    Google Scholar 

  • Van Helden HPM, Van der Wiel HJ, Wolthuis OL (1988) Retention of soman in rats, guinea-pigs and marmosets: species-dependent effects of the soman simulator, pinacolyl dimethylphosphinate (PDP). J Pharm Pharmacol 40: 35–41

    Google Scholar 

  • Wolthuis O, Vanwersch RAP, Van der Wiel HJ (1981) The efficacy of soman bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man. Eur J Pharmacol 70: 355–369

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grubič, Z., Tomažič, A. Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2. Arch Toxicol 63, 68–71 (1989). https://doi.org/10.1007/BF00334637

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00334637

Key words

Navigation